chitosan has been researched along with Nerve Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paulose, CS; Shilpa, J | 1 |
| Skaper, SD | 1 |
| Kim, SK; Pangestuti, R | 1 |
1 review(s) available for chitosan and Nerve Degeneration
| Article | Year |
|---|---|
Neuroprotective properties of chitosan and its derivatives.
Topics: Apoptosis; Chitosan; Humans; Nerve Degeneration; Neurons; Neuroprotective Agents | 2010 |
2 other study(ies) available for chitosan and Nerve Degeneration
| Article | Year |
|---|---|
GABA and 5-HT chitosan nanoparticles decrease striatal neuronal degeneration and motor deficits during liver injury.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Chitosan; Cytokines; Drug Delivery Systems; gamma-Aminobutyric Acid; Insulin-Like Growth Factor I; Liver; Liver Diseases; Male; Microscopy, Confocal; Motor Skills Disorders; Nanoparticles; Nerve Degeneration; Neuroglia; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Serotonin; Tumor Necrosis Factor-alpha | 2014 |
Nanoparticles deliver the goods.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Blood-Brain Barrier; Caspase 3; Cerebral Arteries; Chitosan; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelial Cells; Humans; Hypoxia-Ischemia, Brain; Mice; Nanoparticles; Nerve Degeneration; Receptors, Transferrin; Treatment Outcome | 2010 |